Vulvovaginitis clinical trials

The registry lists 13 studies for Vulvovaginitis across more than 10 countries. 2 are recruiting or about to start. 4 of them are mainly about Vulvovaginitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-23. Counting its narrower condition Candidiasis, Vulvovaginal too: 116 studies, 15 open.

Get an email when these change. Save the Vulvovaginitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 9
Recruiting: 2
Status unknown: 1
Withdrawn: 1

Phase

Phase 2: 3
Phase 3: 2

Where

United States: 4
Sweden: 3
Romania: 2
India: 2
Italy: 1
Poland: 1

Who runs them

Gedea Biotech AB (3) · Matinas BioPharma Nanotechnologies, Inc. (2) · Perfect Care Distribution (2) · GlaxoSmithKline (1) · UPECLIN HC FM Botucatu Unesp (1) · Lumara Health, Inc. (1) · ProFem GmbH (1) · Nanopath, Inc (1)

What is being tested here

Drugs under test in Vulvovaginitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Encochleated Amphotericin B	0	2
Clindamycin phosphate	1	1
Clindamycin	1	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Dec 2026Large Algorithm Setting and Validation Study · Nanopath, Inc

Who these studies take

Of the 2 Vulvovaginitis studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (50%) take children under 18. 2 (100%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	1 (50%)	0 (0%)
18	2 (100%)	0 (0%)
30	2 (100%)	0 (0%)
40	2 (100%)	0 (0%)
50	2 (100%)	0 (0%)
65	2 (100%)	0 (0%)
75	2 (100%)	0 (0%)
85	2 (100%)	0 (0%)

Across all 13 studies, recruiting or not: 31% stop at 75 or younger and 31% at 65; 23% take children; 100% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 13 of 13. search them.